A novel anti-PSMA human scFv has the potential to be used as a diagnostic tool in prostate cancer

Prostate cancer (PCa) is the most commonly diagnosed malignancy and the second leading cause of cancer related death in men. The early diagnosis and treatment of PCa are still challenging due to the lack of efficient tumor targeting agents in traditional managements. Prostate specific membrane antig...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Han, Donghui, Wu, Jieheng, Han, Yueheng, Wei, Ming, Han, Sen, Lin, Ruihe, Sun, Ziyong, Yang, Fa, Jiao, Dian, Xie, Pin, Zhang, Lingling, Yang, An-Gang, Zhao, Aizhi, Wen, Weihong, Qin, Weijun
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2016
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5312325/
https://ncbi.nlm.nih.gov/pubmed/27448970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10697
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia